1. Home
  2. CTMX vs CLW Comparison

CTMX vs CLW Comparison

Compare CTMX & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • CLW
  • Stock Information
  • Founded
  • CTMX 2008
  • CLW 2005
  • Country
  • CTMX United States
  • CLW United States
  • Employees
  • CTMX N/A
  • CLW N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • CLW Paper
  • Sector
  • CTMX Health Care
  • CLW Basic Materials
  • Exchange
  • CTMX Nasdaq
  • CLW Nasdaq
  • Market Cap
  • CTMX 444.3M
  • CLW 458.4M
  • IPO Year
  • CTMX 2015
  • CLW N/A
  • Fundamental
  • Price
  • CTMX $2.48
  • CLW $29.89
  • Analyst Decision
  • CTMX Strong Buy
  • CLW Buy
  • Analyst Count
  • CTMX 2
  • CLW 1
  • Target Price
  • CTMX $5.00
  • CLW $37.00
  • AVG Volume (30 Days)
  • CTMX 2.7M
  • CLW 181.2K
  • Earning Date
  • CTMX 08-07-2025
  • CLW 08-05-2025
  • Dividend Yield
  • CTMX N/A
  • CLW N/A
  • EPS Growth
  • CTMX 128.27
  • CLW 73.65
  • EPS
  • CTMX 0.49
  • CLW 10.33
  • Revenue
  • CTMX $147,557,000.00
  • CLW $1,503,000,000.00
  • Revenue This Year
  • CTMX N/A
  • CLW $15.71
  • Revenue Next Year
  • CTMX N/A
  • CLW $1.44
  • P/E Ratio
  • CTMX $5.11
  • CLW $2.89
  • Revenue Growth
  • CTMX 23.81
  • CLW 72.88
  • 52 Week Low
  • CTMX $0.40
  • CLW $22.58
  • 52 Week High
  • CTMX $3.10
  • CLW $57.13
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 56.59
  • CLW 62.44
  • Support Level
  • CTMX $2.15
  • CLW $27.02
  • Resistance Level
  • CTMX $2.44
  • CLW $28.95
  • Average True Range (ATR)
  • CTMX 0.24
  • CLW 0.90
  • MACD
  • CTMX -0.05
  • CLW 0.14
  • Stochastic Oscillator
  • CTMX 39.71
  • CLW 95.17

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CLW Clearwater Paper Corporation

Clearwater Paper Corp is engaged in the manufacturing and supplier of Solid Bleached Sulfate (SBS) paperboard packaging products. The company products includes: SBS paperboard which is a premium paperboard grade that is frequently used to produce folding cartons, food service, commercial printing items. It generates maximum revenue from Pulp and Paperboard segment. Company operate in United States and have globalized access too. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: